Agamatrix And Sanofi Diabetes Global Partnership
Salem, New Hampshire, March 31, 2010 Xinhua, AgaMatrix, Inc. And Sanofi – Aventis (sanofi-aventis) (EURONEXT: SAN and NYSE: SNY) announced today that they have on the development, supply and Sell Blood glucose monitoring (BGM) solutions, signed a long-term agreement. Under the terms of the agreement, AgaMatrix and Sanofi – Aventis will use AgaMatrix the WaveSense (TM) technology, Cooperation Development of innovative Diabetes Control solutions. Sanofi – Aventis, through its Global Diabetes sector (GlobalDiabetesDivision) to promote sales for a comprehensive solution with diabetes, and Sanofi – Aventis insulin and delivery devices available. Sanofi – Aventis combination of insulin and delivery devices, including the world’s number one specified basal insulin Lantus (R) (Lantus (R)) and the leading quick Insulin Apidra (R), as well as easy-to-use injection devices SoloSTAR (R ) and CLikSTAR (R).
Sanofi – Aventis choose AgaMatrix as its global partners because AgaMatrix products in the market with high precision and innovative edge. Accurate adjustment for the insulin dose for the patient safety is particularly important.
Sanofi – Aventis the world’s diabetes department, vice president of device strategy EricPetreto said: “In the establishment of a global diabetes department, our goals include the full range of search potential partners, they have outstanding core scientific, high sense of innovation, and develops a wide range of products. We have found AgaMatrix, it can fully satisfy our blood glucose monitoring in respect of the three objectives set. ”
AgaMatrix proprietary WaveSense technology to personalize each test set to provide world-class accuracy, the process needs to be called the dynamic using a new electrochemical detection method, the blood samples, production the process of change and differences in environmental conditions caused by the error detection and correction. In addition, the completion of the test very quickly, required very little blood, and without coding.
AgaMatrix SonnyVu and SridharIyengar co-founder, said: “We are to patients, healthcare professionals and industry leaders, the message is always the need for more accurate diabetes blood sugar testing, and our WaveSense technology can provide this high precision, so we are naturally delighted to find a partner with shared values. with Sanofi – Aventis’s global influence and good reputation, we believe this partnership will enable us to finally achieve our first the idea that patients all over the world can easily obtain high accuracy blood glucose monitoring. ”
AgaMatrix Description:
AgaMatrix is a privately held company headquartered in Salem, New Hampshire, dedicated to creating, developing, manufacturing and marketing of a series of blood glucose meters, bio-sensors (test strips) and diabetes control software. AgaMatrix’s products are designed by using the company’s proprietary WaveSense technology, personalized settings for each test to provide world class accuracy. The technology uses a new type called dynamic electrochemical detection method, blood samples and by the differences in environmental conditions caused by the large number of error detection and correction. AgaMatrix’s existing products include WaveSenseKeyNote (TM), Presto (TM), WaveSenseJazz (TM) BGMs and WaveSenseDiabetesManager (TM) iPhone (R) App. AgaMatrix’s WaveSense Series Detector And the test strip, from insurance companies, mail order and can be purchased in retail stores in general. For more product information, please visit: http://www.agamatrix.com.
I am China Manufacturers writer, reports some information about barites , custom moulds.
Processing your request, Please wait....
